Walther Cancer Foundation has pledged $10 million to Riley Children’s Foundation for children’s cancer research.
Mariza Daras was named chief of the Division of Neuro-Oncology at VCU Massey Cancer Center and the Department of Neurology at VCU School of Medicine.
David Wheeler, member of the Cancer Prevention and Control research program at VCU Massey Cancer Center, was awarded a five-year, $1.7 million R01 grant from NCI to study thelong-term effects of neighborhood exposures and racial segregation on cancer risk through the use of innovative statistical models and analysis.
A team of clinical psychologists at VCU Massey Cancer Center received a four-year, $1.5 million grant from the U.S. Department of Defense to help treat insomnia among military members, veterans, their beneficiaries and the general public who have been diagnosed with brain cancer.
ChristianaCare received a $1 million gift from the Bacchieri Family to support the purchase of a state-of-the-art radiography system to analyze breast cancer specimens at the Helen F. Graham Cancer Center & Research Institute and expand a fellowship program to reduce disparities in breast and lung cancer.
NCI has selected Exact Sciences Corp.’s testing laboratory in Phoenix, AZ to participate in the ComboMATCH clinical trials, an NCI-funded precision medicine initiative. As a ComboMATCH-designated lab, Exact Sciences will use its new OncoExTra test to analyze tumor tissue and paired normal blood samples from patient participants and uncover the specific abnormalities in a patient’s tumor that may be most effective to treat.
BriaCell Therapeutics Corp. received an NCI research grant to advance the company’s platform of personalized off-the-shelf immunotherapies for cancer. The grant award of non-dilutive funds, totalling $399,918 for 2023, is titled “An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors.”
The Association of Community Cancer Centers—with its partners, the Association of Oncology Social Work and the American Psychosocial Oncology Society—is calling for sweeping improvements to mental health care services and support for patients, caregivers, and mental health care professionals experiencing psychological distress.
The Dr. Robert H. and Mary Ellen Harris ZAP-X Center for Noninvasive Neurosurgery at the Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center will debut their ZAP-X Gyroscopic Radiosurgery for treatment of brain tumors and other conditions of the head and neck and will pair the Zap-X with Synaptive Medical Inc.’s brain-only, silent MRI, with the goal of shortening the time from diagnosis to treatment.
Thyme Care raised $60 million in series B funding, co-led by Town Hall Ventures and Foresite Capital and with participation from current investors Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital, and Frist Cressey Ventures. The capital brings Thyme Care’s total capital raised to over $80 million (The Cancer Letter, Oct. 7, 2022).
